MediPal Corporation (MAHLY)
16.35
-0.15 (-0.91%)
At close: Apr 22, 2025, 3:58 PM
-0.91% (1D)
| Bid | 15.4 |
| Market Cap | 3.4B |
| Revenue (ttm) | 3,581.3B |
| Net Income (ttm) | 39.29B |
| EPS (ttm) | 1.68 |
| PE Ratio (ttm) | 9.73 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 17 |
| Volume | 503 |
| Avg. Volume (20D) | 269 |
| Open | 16.50 |
| Previous Close | 16.50 |
| Day's Range | 16.35 - 16.50 |
| 52-Week Range | 14.03 - 19.07 |
| Beta | 0.02 |
About MAHLY
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved i...
Industry Medical - Distribution
Sector Healthcare
IPO Date Oct 6, 2009
Employees 13,075
Stock Exchange PNK
Ticker Symbol MAHLY
Website https://www.medipal.co.jp